| Metric | Value (₹ Cr) | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue | 2.3K | 3.1% | 29.6% |
| Total Income | 2.4K | 3.9% | 30.3% |
| Expenditure | 2.1K | 3.8% | 19.7% |
| PBT | 220.85 | 4.8% | 841.4% |
| Net Profit | 179.67 | 5.0% | 436.3% |
| OPM | 12.41% | 0.74pp | 6.69pp |
| NPM | 7.59% | 0.08pp | 5.75pp |
| EPS | 31.93 | 10.1% | 305.7% |
Detailed report is being prepared.
Profitability momentum enters second quarter—margins at inflection point
After Q1's explosive profit swing on margin recovery and pricing gains, Polyplex faces expectations of sustained operational outperformance. The Street sees room to run; watch whether quarterly gains hold through capacity integration and forex headwinds.
What to Expect
~₹2,250–2,350 Cr
Implied ~25% YoY growth; Q1 momentum (+20.5% QoQ) suggests on-plan trajectory in a stable resin environment
~₹140–180 Cr
Q1 FY27 posted ₹171 Cr vs ₹37.6 Cr in Q4 FY26—watch whether margin gains hold under any cost-inflation or currency headwind
~14–16%
Normalized margin guided at 12% FY27E; Q1's 16% reflects strong pricing power and operational leverage. Sustainability is the debate.
~₹125 Cr
Core unit driving the story; Q1 posted ₹125 Cr. Expect similar scale absent one-time hedges.
A strong Q2 means: revenue tracking 25%+ YoY growth, EBITDA margin holding 14%+, and profit near ₹170 Cr or above—signaling pricing discipline across polyester film segments (BOPET, BOPP) and no surprise cost inflation. Weak scenario: revenue misses 22% YoY growth, margins compress below 12%, or profit falls to ₹130 Cr—would flag FX headwinds, softer demand, or input cost spikes.
On Track for Guidance?
Polyplex's FY27E consensus sets EBITDA margin at 12% and PAT CAGR at 95.4% over FY24–27E. Q1 FY27's 16% EBITDA margin already exceeds the full-year target, but that may reflect temporary pricing tailwinds. The key: is the company maintaining 12%+ normalized margins through H2? Q2 will signal whether the margin inflection is structural (better pricing power + mix) or cyclical (transient resin deflation). Recent capacity expansion in Thailand (12k MT BOPP/BOPE) and PDPL acquisition (₹73.5 Cr finalized) suggest management confidence in sustained demand, but both are in build/integration phase—earnings accretion delayed into H2/FY28.
What the Street Says
Since Last Quarter: Filing Scan
1 · Interim dividend signaled (Nov 7–11)
Board to consider interim dividend for FY27 on Nov 13. Indicates management confidence in cash generation post-margin recovery.
2 · Share sale agreement revised (Nov 6)
AGP HoldCo (Investor) and Promoter Group revised timelines on call-option share sale. Promoter stake stable at 26.73%; no material shareholder flux.
3 · Thai capacity +12k MT (Oct 7)
Polyplex (Thailand) approved second-hand BOPP/BOPE line; 6.6m five-layer setup. Accretive post-FY27; near-term cost/integration risk.
4 · PDPL acquisition finalized (Oct 1)
51% stake purchase consideration settled at ₹73.5 Cr. Accretion expected H2 FY27 onward; operations integrating now.
5 · 41st AGM held (Sep 8)
Routine shareholder meeting; final dividend ₹1 per share approved. No material governance changes.
6 · BRSR filed (Aug 14)
ESG compliance routine; no red flags from sustainability standpoint.
The Setup
Polyplex enters Q2 with profitable momentum: Q1 FY27 posted consolidated profit of ₹171 Cr on a 16% EBITDA margin—a stark reversal from Q1 FY26's loss. The swing reflects operational discipline (cost control), pricing gains in polyester and BOPP films, and stable resin/feedstock costs. The Street sees durable margin recovery (Street target 12% FY27E vs historical 7–10%) backed by improving pricing power and mix. Stock is priced at 65% discount to 52-week high; FII ownership crept up 30 bps QoQ to 10.22%. On Nov 13, the board will declare an interim dividend—a vote of confidence—alongside Q2 results.
Three Things to Watch on Result Day
1 · Does margin hold 12%+ EBITDA?
Q1's 16% may be a peak due to favorable polymer pricing. If Q2 EBITDA margin stays 12%+, the margin inflection is real; if it drops below 11%, it signals cyclicality and raises FY27 guidance questions.
2 · Revenue growth trajectory—is 25%+ YoY sustainable?
Q1 grew 29.6% YoY; Q2 guidance visibility into demand (domestic film, export, specialty) will shape FY27 revenue CAGR. Weak Q2 could flag demand slowdown.
3 · Dividend quantum & FY27 payout intent
Interim dividend size signals cash deployment confidence. Combined with capex (Thailand, PDPL), watch for FY27 payout ratio guidance—high payout + execution on expansion = credible growth signal.
Polyplex is at a genuine profitability inflection: Q1 delivered, and margin recovery is attracting Street attention (BUY consensus, ₹2,460 target). Q2 will test whether the swing is structural or transient. On track for guidance if EBITDA margin stays 12%+ and revenue growth holds 23%+ YoY; the bar is high but achievable given recent data. Watch for execution risk on Thai and PDPL integrations—early signal of management's capital discipline.